Future of drugs-Heart Disease & Stroke_Vernakalant
Drug Name Vernakalant Structure Drug Code RSD1235 Synonym Kynapid, Brinavess (3R)-1-{(1R,2R)-2-[2-(3,4-dimethoxyphenyl)ethoxy] cyclohexyl}pyrrolidin-3-ol Molecular Formula C 20 H 31 NO 4 Innovator Cardiome Pharma Corp Merck Condition Prevention of post-operative atrial fibrillation in patients undergoing coronary artery bypass graft surgery. Mechanism of Action Blocks atrial potassium and sodium channels Clinical Phase Not yet approved. (Filed for Orphan Drug Designation) Approved in Europe.